JP2022504707A - 芳香族化合物およびその医薬用途 - Google Patents

芳香族化合物およびその医薬用途 Download PDF

Info

Publication number
JP2022504707A
JP2022504707A JP2021519840A JP2021519840A JP2022504707A JP 2022504707 A JP2022504707 A JP 2022504707A JP 2021519840 A JP2021519840 A JP 2021519840A JP 2021519840 A JP2021519840 A JP 2021519840A JP 2022504707 A JP2022504707 A JP 2022504707A
Authority
JP
Japan
Prior art keywords
group
atoms
double bonds
alkyl group
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021519840A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022504707A5 (enExample
Inventor
スクジェレット，トーレ
アラン フレーザー，デヴィッド
ハーマンセン スタインガー，ヒルデ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pronova Biopharma Norge AS
Original Assignee
Pronova Biocare AS
Pronova Biopharma Norge AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pronova Biocare AS, Pronova Biopharma Norge AS filed Critical Pronova Biocare AS
Publication of JP2022504707A publication Critical patent/JP2022504707A/ja
Publication of JP2022504707A5 publication Critical patent/JP2022504707A5/ja
Priority to JP2024073580A priority Critical patent/JP2024122966A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/28—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups having unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/46—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/62—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/04—Monocyclic monocarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/64—Monocyclic acids with unsaturation outside the aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/12—Acetic acid esters
    • C07C69/16—Acetic acid esters of dihydroxylic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2021519840A 2018-10-11 2019-10-10 芳香族化合物およびその医薬用途 Pending JP2022504707A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024073580A JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862744461P 2018-10-11 2018-10-11
US62/744,461 2018-10-11
PCT/IB2019/001139 WO2020074964A1 (en) 2018-10-11 2019-10-10 Romatic compounds and pharmaceutical uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024073580A Division JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Publications (2)

Publication Number Publication Date
JP2022504707A true JP2022504707A (ja) 2022-01-13
JP2022504707A5 JP2022504707A5 (enExample) 2022-10-18

Family

ID=68655570

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021519840A Pending JP2022504707A (ja) 2018-10-11 2019-10-10 芳香族化合物およびその医薬用途
JP2024073580A Pending JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024073580A Pending JP2024122966A (ja) 2018-10-11 2024-04-30 芳香族化合物およびその医薬用途

Country Status (16)

Country Link
US (2) US12473249B2 (enExample)
EP (1) EP3864001A1 (enExample)
JP (2) JP2022504707A (enExample)
KR (1) KR20210091150A (enExample)
CN (2) CN113166024B (enExample)
AU (2) AU2019358595B2 (enExample)
CA (1) CA3112073A1 (enExample)
CL (1) CL2021000846A1 (enExample)
CO (1) CO2021006087A2 (enExample)
EA (1) EA202190890A1 (enExample)
IL (1) IL282134A (enExample)
MA (1) MA53188A1 (enExample)
MX (1) MX2021003750A (enExample)
PH (1) PH12021550744A1 (enExample)
SG (1) SG11202103011YA (enExample)
WO (1) WO2020074964A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023065200A1 (en) * 2021-10-21 2023-04-27 Givaudan Sa Organic compounds
WO2024206117A1 (en) 2023-03-24 2024-10-03 Northsea Therapeutics B.V. Benzoic acid derivatives for use in methods of treating intestinal failure-associated liver disease in children

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013100289A (ja) * 2006-07-31 2013-05-23 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 メタロ−β−ラクタマーゼ阻害剤
JP5526018B2 (ja) * 2007-03-21 2014-06-18 エミスフェアー・テクノロジーズ・インク アリルオキシおよびアルキルオキシ安息香酸送達薬剤

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5210266A (en) * 1987-12-03 1993-05-11 Dainippon Pharmaceutical Co., Ltd. N-substituted mercaptopropanamide derivatives
EP0637957B1 (de) 1992-04-28 1997-07-23 Fresenius AG Verwendung einer omega-3-fettsäuren enthaltenden emulsion zur herstellung eines parenteral zu verabreichenden arzneimittels zur behandlung von entzündlichen erkrankungen
DK1900364T3 (da) 2001-04-18 2014-01-13 Prometic Biosciences Inc Fedtsyrer, glycerider og analoger med medium kædelængde som neutrofile overlevelses- og aktiveringsfaktorer
RU2341513C2 (ru) * 2001-06-12 2008-12-20 Веллстат Терапьютикс Корпорейшн Соединения для лечения метаболических заболеваний
US7553867B2 (en) 2002-09-06 2009-06-30 Takeda Pharmaceutical Company Limited Furan or thiophene derivative and medicinal use thereof
WO2006066894A1 (en) 2004-12-24 2006-06-29 Ctg Pharma S.R.L. Compounds for treating metabolic syndrome
AU2004210082B2 (en) * 2003-02-06 2011-03-17 Dompe' Farmaceutici S.P.A. 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
BRPI0407276A (pt) 2003-02-07 2006-01-31 Prometic Biosciences Inc ácidos graxos, glicerìdeos e análogos com comprimento de cadeia médio, como estimulantes de eritropoiese
ES2530235T3 (es) * 2003-02-13 2015-02-27 Wellstat Therapeutics Corporation Compuestos para el tratamiento de trastornos metabólicos
PL1648851T3 (pl) 2003-07-25 2007-09-28 Prometic Biosciences Inc Wytwarzanie soli średniołańcuchowych kwasów tłuszczowych z metalami
ES2372694T3 (es) * 2003-10-15 2012-01-25 OSI Pharmaceuticals, LLC Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina.
US20070111989A1 (en) 2003-12-05 2007-05-17 Olivier Bezencon Novel diazabicyclononene derivatives and use
AP2007003939A0 (en) 2004-09-03 2007-04-30 Prometic Biosciences Inc Substituted purinyl derivatives with immunomodulator and chemoprotective activity and use alone or with medium-chain length fatty acids or glycerides
US8071580B2 (en) 2004-10-01 2011-12-06 Prometic Biosciences Inc. Medium-chain length fatty alcohols as stimulators of hematopoiesis
EA200700741A1 (ru) 2004-10-01 2007-08-31 Прометик Байосайенсиз Инк. Жирные спирты со средней длиной цепи как стимуляторы гематопоэза
TW200724138A (en) * 2005-03-29 2007-07-01 Sk Corp Substituted carboxylic acid derivatives for the treatment of diabetes and lipid disorders, their preparation and use
CN101218199A (zh) 2005-05-09 2008-07-09 阿斯利康(瑞典)有限公司 新化合物ⅰ
GB0522433D0 (en) 2005-11-03 2005-12-14 Astrazeneca Ab Therapeutic agents
RU2008136898A (ru) 2006-02-15 2010-03-20 Санофи-Авентис (Fr) Азациклил-замещенные арилдигидроизохинолиноны, способ их получения и их применение в качестве лекарственных средств
WO2008151211A1 (en) * 2007-06-05 2008-12-11 Sanofi-Aventis Substituted benzoylamino-indan-2-carboxylic acids and related compounds
US9532962B2 (en) 2007-11-02 2017-01-03 Prometic Pharma Smt Limited Medium-chain length fatty acids and glycerides as nephroprotection agents
JP5473937B2 (ja) 2007-12-19 2014-04-16 プロメティック・バイオサイエンシーズ・インコーポレイテッド 膵臓癌の治療のためのゲムシタビンと併用した中鎖脂肪酸、その塩およびトリグリセリド
KR20100135793A (ko) * 2008-03-13 2010-12-27 바스프 에스이 이량체 벤질리덴 말로네이트
CN102088965B (zh) 2008-05-13 2013-05-08 根梅迪卡治疗公司 水杨酸盐(酯)缀合物在制备用于治疗代谢性病症的药物中的应用
JP2012503595A (ja) * 2008-07-28 2012-02-09 シダンスク ユニバーシティ 代謝病の治療用の化合物
EP2427416B1 (en) 2009-05-04 2016-03-09 Prometic Pharma Smt Limited Substituted aromatic compounds and pharmaceutical uses thereof
KR101783817B1 (ko) * 2009-05-08 2017-10-23 프로노바 바이오파마 너지 에이에스 심혈관 질병, 대사 질병, 및 염증성 질환 분야관련 질병의 치료를 위한 다중 불포화 지방산
EA022120B1 (ru) * 2009-10-20 2015-11-30 Целльзом Лимитид Аналоги гетероциклил пиразолопиримидина в качестве ингибиторов jak
ES2441665T3 (es) 2009-11-26 2014-02-05 Genfit Utilización de derivados de 1,3-difenilprop-2-en-1-ona para tratar trastornos hepáticos
TWI572352B (zh) 2012-03-01 2017-03-01 波麥堤克藥學Ｓｍｔ有限公司 用於製備具中鏈長度之脂肪酸的三酸甘油酯之方法
US9562041B2 (en) * 2012-05-16 2017-02-07 Glaxosmithkline Llc Enhancer of zeste homolog 2 inhibitors
TWI689490B (zh) 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
TWI742541B (zh) 2013-03-15 2021-10-11 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
WO2015179697A1 (en) 2014-05-21 2015-11-26 Taxis Pharmaceuticals, Inc. Compounds for the treatment of bacterial infections
SG11201702812PA (en) 2014-10-10 2017-05-30 Prometic Pharma Smt Ltd Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
GB2543478A (en) 2015-09-07 2017-04-26 Manchester Metropolitan Univ Glycomimetics
KR102793841B1 (ko) 2018-05-08 2025-04-11 가부시키가이샤 아데카 화합물, 잠재성 첨가제, 조성물, 경화물, 경화물의 제조 방법 및 조성물의 제조 방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013100289A (ja) * 2006-07-31 2013-05-23 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 メタロ−β−ラクタマーゼ阻害剤
JP5526018B2 (ja) * 2007-03-21 2014-06-18 エミスフェアー・テクノロジーズ・インク アリルオキシおよびアルキルオキシ安息香酸送達薬剤

Non-Patent Citations (18)

* Cited by examiner, † Cited by third party
Title
DATABASE REGISTRY, RN 1369914-68-0, RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7024003174, 18 April 2012 (2012-04-18), ISSN: 0005379917 *
DATABASE REGISTRY, RN 1511639-69-2，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004091, 5 January 2014 (2014-01-05), ISSN: 0005186285 *
DATABASE REGISTRY, RN 1546111-99-2 ，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004090, 17 February 2014 (2014-02-17), ISSN: 0005186284 *
DATABASE REGISTRY, RN 1548191-86-1，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004089, 18 February 2014 (2014-02-18), ISSN: 0005186283 *
DATABASE REGISTRY, RN 1555154-56-7，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004088, 25 February 2014 (2014-02-25), ISSN: 0005186282 *
DATABASE REGISTRY, RN 2024714-26-7，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004087, 4 November 2016 (2016-11-04), ISSN: 0005186281 *
DATABASE REGISTRY, RN 2091366-89-9，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004086, 18 April 2017 (2017-04-18), ISSN: 0005186280 *
DATABASE REGISTRY, RN 2140641-42-3, RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7024003175, 10 November 2017 (2017-11-10), ISSN: 0005379916 *
DATABASE REGISTRY, RN 2149334-28-9，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004082, 1 December 2017 (2017-12-01), ISSN: 0005186276 *
DATABASE REGISTRY, RN 2152384-84-2 ，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004085, 6 December 2017 (2017-12-06), ISSN: 0005186279 *
DATABASE REGISTRY, RN 2154491-13-9, RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7024003176, 10 December 2017 (2017-12-10), ISSN: 0005379915 *
DATABASE REGISTRY, RN 2159228-81-4，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004081, 17 December 2017 (2017-12-17), ISSN: 0005186275 *
DATABASE REGISTRY, RN 2159369-73-8，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004080, 17 December 2017 (2017-12-17), ISSN: 0005186274 *
DATABASE REGISTRY, RN 2164064-45-1, RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7024003177, 24 December 2017 (2017-12-24), ISSN: 0005379914 *
DATABASE REGISTRY, RN 2164401-87-8，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004084, 24 December 2017 (2017-12-24), ISSN: 0005186278 *
DATABASE REGISTRY, RN 2172065-09-5，RETRIEVED FROM STN INTERNATIONAL [ONLINE], JPN7023004083, 31 January 2018 (2018-01-31), ISSN: 0005186277 *
LE THI NGOC CHUC ET AL.: "Long-Range Olefin Isomerization Catalyzed byPalladium(0) Nanoparticles", ACS OMEGA, vol. 2, no. 2, JPN6023044828, 27 February 2017 (2017-02-27), pages 698 - 711, ISSN: 0005186287 *
NICHOLAS W. HIRD ETAL.: "Synthesis and β-lactamase inhibition of anacardic acids and their analogues", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 4, no. 12, JPN6023044829, June 1994 (1994-06-01), pages 1423 - 1428, ISSN: 0005186286 *

Also Published As

Publication number Publication date
KR20210091150A (ko) 2021-07-21
CN120923343A (zh) 2025-11-11
AU2019358595A1 (en) 2021-05-27
CN113166024A (zh) 2021-07-23
CA3112073A1 (en) 2020-04-16
SG11202103011YA (en) 2021-04-29
EP3864001A1 (en) 2021-08-18
CN113166024B (zh) 2025-07-18
JP2024122966A (ja) 2024-09-10
CL2021000846A1 (es) 2021-11-12
US20260184664A1 (en) 2026-07-02
MA53188A1 (fr) 2021-12-31
US12473249B2 (en) 2025-11-18
US20210380521A1 (en) 2021-12-09
IL282134A (en) 2021-05-31
WO2020074964A1 (en) 2020-04-16
PH12021550744A1 (en) 2022-02-21
BR112021006907A2 (pt) 2021-09-08
AU2019358595B2 (en) 2025-04-17
EA202190890A1 (ru) 2021-09-10
AU2025205518A1 (en) 2025-08-07
MX2021003750A (es) 2021-06-15
CO2021006087A2 (es) 2021-08-09

Similar Documents

Publication Publication Date Title
KR101783817B1 (ko) 심혈관 질병, 대사 질병, 및 염증성 질환 분야관련 질병의 치료를 위한 다중 불포화 지방산
AU2010236663B2 (en) Compositions and methods for the treatment of inflammation
JP2021183628A (ja) カルビドパおよびｌ−ドーパプロドラッグならびにそれらの使用方法
US20150299103A1 (en) Prodrugs of monomethyl fumarate (mmf)
JP2024122966A (ja) 芳香族化合物およびその医薬用途
CN105189438A (zh) 用于治疗纤维化的经取代的芳族化合物及相关方法
WO2021036514A1 (zh) 一类PPARγ/δ双重激动剂、其制备方法及其作为药物的用途
WO2021032218A1 (zh) 一种并环THRβ受体激动剂化合物及其制备方法和用途
JP2025521519A (ja) 脂肪酸化合物
JP2021523934A (ja) ミトコンドリア脱共役剤として有用なアミノピラジンおよび関連化合物
US20200131212A1 (en) Compound for treating metabolic diseases and preparation method and use thereof
KR101360579B1 (ko) 신규 페닐초산 유도체
WO2020245291A1 (en) Pyrrole derivatives as acc inhibitors
BR112021006907B1 (pt) Compostos aromáticos, composição farmacêutica e usos da referida composição
CA3147789A1 (en) Heterocyclic thr-.beta. receptor agonist compound and preparation method and use therefor
BR122025017301A2 (pt) Compostos aromáticos, composição e usos farmacêuticos destes
WO2020245297A1 (en) Pyrrole derivatives as acc inhibitors
JP7449283B2 (ja) ビアリール誘導体
US20260001833A1 (en) Compounds, compositions, and methods for reducing production of trimethylamine
US20200239473A1 (en) New derivatives of licofelone
US20180305292A1 (en) Derivatives of nonsteroidal anti-inflammatory drugs
WO2009024022A1 (fr) Conjugués acides gras-acides biliaires et leurs utilisations médicales
JP2023142282A (ja) 繊維化が生じる疾患の治療用医薬用組成物
CN119192155A (zh) 一种治疗阿尔茨海默症的药物及其制备方法
WO2021166998A1 (ja) レゾルビンｅ２の安定等価体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221007

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221007

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20230914

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20231031

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240125

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240325

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240430

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20240730